Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Stoke Therapeutics, Inc. - Common Stock
(NQ:
STOK
)
35.15
+0.28 (+0.80%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Stoke Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Crude Oil Up 1%; Verizon Earnings Beat Views
↗
July 25, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05....
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
July 25, 2023
Via
Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
July 25, 2023
Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.
Via
Benzinga
What 8 Analyst Ratings Have To Say About Stoke Therapeutics
↗
June 26, 2023
Via
Benzinga
Analyst Expectations for Stoke Therapeutics's Future
↗
June 08, 2023
Via
Benzinga
Why Stoke Therapeutics Is Trading Lower Today?
↗
July 25, 2023
Stoke Therapeutics Inc (NASDAQ: STOK) shares are trading lower after the company released new safety & efficacy data from STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 25, 2023
Via
Benzinga
Analyst Ratings for Stoke Therapeutics
↗
June 08, 2023
Via
Benzinga
12 Analysts Have This to Say About Stoke Therapeutics
↗
May 23, 2023
Via
Benzinga
Where Stoke Therapeutics Stands With Analysts
↗
May 23, 2023
Via
Benzinga
Stoke Therapeutics: Q1 Earnings Insights
↗
May 04, 2023
Via
Benzinga
Stoke Therapeutics Announces Positive New Safety & Efficacy Data from Patients Treated with STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) Study in Children and Adolescents with Dravet Syndrome
July 25, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Scholastic, Matson, Digital World Acquisition And Other Big Stocks Moving Higher On Friday
↗
July 21, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 90 points on Friday. Here are some big stocks recording gains in today’s session. Digital World Acquisition Corp. (NASDAQ: DWAC) climbed 69%...
Via
Benzinga
Stoke Therapeutics to Host Webinar to Present New Data from Patients Treated with STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) Study in Children and Adolescents with Dravet Syndrome
July 21, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
What 7 Analyst Ratings Have To Say About Stoke Therapeutics
↗
April 26, 2023
Via
Benzinga
Credit Suisse Maintains Outperform Rating for Stoke Therapeutics: Here's What You Need To Know
↗
March 07, 2023
Via
Benzinga
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
July 24, 2023
Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
June 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 21, 2023
Via
Benzinga
6 Analysts Have This to Say About Stoke Therapeutics
↗
March 07, 2023
Via
Benzinga
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
June 16, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Adobe And 2 Other Stocks Insiders Are Selling
↗
May 04, 2023
The S&P 500 closed lower on Wednesday after the Fed increased rates by 25 basis points, as widely expected. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
May 04, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present at the BofA Securities Health Care Conference
May 03, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
↗
May 01, 2023
Via
Benzinga
Stoke Therapeutics Receives Authorization to Initiate a Phase 1/2 Study of STK-002 for Autosomal Dominant Optic Atrophy (ADOA) in the United Kingdom
April 25, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Announces That FDA Will Allow the Administration of a Higher Single Dose of STK-001 (70mg) in the Ongoing Phase 1/2a MONARCH Study of Children and Adolescents with Dravet Syndrome
March 15, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
March 06, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Participate at Upcoming March Investor Conferences
February 27, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
